Home/Filamon/Paul De Souza
PD

Paul De Souza

Deputy CEO, Co‑Founder and Non‑Executive Director

Filamon

Filamon Pipeline

DrugIndicationPhase
KESONOTIDE™Broad chronic inflammatory diseasesPreclinical
BETA‑TT8Cancer, cardiovascular disease, neuroinflammatory eye conditionsPreclinical